Search for an ETF or holding
ARK Genomic Revolution ETF
ARKG (ARK Genomic Revolution ETF) is an US Equity ETF by ARK. With a 0.75% MER, it provides diversified exposure through 35 holdings.
ARKG is an ETF offered by ARK.
With a 0.75% MER, its fees are in line with category averages. It does not pay a significant distribution — returns are reinvested for capital growth.
As a US-listed ETF, it is typically held in an RRSP to minimize withholding tax on US dividends (Canada-US tax treaty).